ATE274600T1 - Verfahren zur bestimmung der blutgerinnung in plasma - Google Patents

Verfahren zur bestimmung der blutgerinnung in plasma

Info

Publication number
ATE274600T1
ATE274600T1 AT99928416T AT99928416T ATE274600T1 AT E274600 T1 ATE274600 T1 AT E274600T1 AT 99928416 T AT99928416 T AT 99928416T AT 99928416 T AT99928416 T AT 99928416T AT E274600 T1 ATE274600 T1 AT E274600T1
Authority
AT
Austria
Prior art keywords
blood
clotting
cti
plasma
methods
Prior art date
Application number
AT99928416T
Other languages
English (en)
Inventor
Kenneth G Mann
Matthew D Rand
Kevin M Cawthern
Original Assignee
Univ Vermont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Vermont filed Critical Univ Vermont
Application granted granted Critical
Publication of ATE274600T1 publication Critical patent/ATE274600T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT99928416T 1998-06-08 1999-06-08 Verfahren zur bestimmung der blutgerinnung in plasma ATE274600T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8848898P 1998-06-08 1998-06-08
PCT/US1999/012631 WO1999064622A1 (en) 1998-06-08 1999-06-08 Inhibition of coagulation in blood and blood products

Publications (1)

Publication Number Publication Date
ATE274600T1 true ATE274600T1 (de) 2004-09-15

Family

ID=22211667

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99928416T ATE274600T1 (de) 1998-06-08 1999-06-08 Verfahren zur bestimmung der blutgerinnung in plasma

Country Status (8)

Country Link
US (2) US6403381B1 (de)
EP (1) EP1084270B1 (de)
JP (1) JP2002517739A (de)
AT (1) ATE274600T1 (de)
AU (1) AU757459B2 (de)
CA (1) CA2333890A1 (de)
DE (1) DE69919702T2 (de)
WO (1) WO1999064622A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE274600T1 (de) * 1998-06-08 2004-09-15 Univ Vermont Verfahren zur bestimmung der blutgerinnung in plasma
AU6369700A (en) * 1999-07-23 2001-02-13 Coagulation Diagnostics, Incorporated Method for measuring coagulant factor activity in whole blood
US20020116222A1 (en) * 2000-10-22 2002-08-22 Standing Stone, Inc. Method and system for administering anticoagulation therapy
US7297716B2 (en) * 2000-10-23 2007-11-20 Shanbrom Technologies, Llc Enhanced production of blood components, blood cells and plasma without freezing
US8389687B2 (en) * 2000-10-23 2013-03-05 Shanbrom Technologies, Llc Polyvinylpyrrolidone cryoprecipitate extraction of clotting factors
US7411006B2 (en) * 2000-10-23 2008-08-12 Shanbrom Technologies, Llc Enhanced production of blood clotting factors and fibrin fabric
US6743596B1 (en) * 2000-10-27 2004-06-01 Biomerieux, Inc. Method of determining global coagulability hemostatic potential
US6645768B1 (en) * 2000-10-27 2003-11-11 Biomerieux, Inc. Reagent and kit for determining global coagulability and hemostatic potential
US7358337B2 (en) * 2002-08-16 2008-04-15 International Technidyne Corporation Assay for low molecular weight heparin
US7235377B2 (en) * 2003-06-09 2007-06-26 The University Of Vermont And State Agriculture College Global test of the hemostatic system
AU2005243161A1 (en) * 2004-05-11 2005-11-24 Heptest Laboratories, Inc. Compositions, kit and one-step method for monitoring compounds having anti-factor Xa and/or anti factor iia activities
US8119137B2 (en) * 2004-12-23 2012-02-21 Csl Behring Gmbh Prevention of thrombus formation and/or stabilization with inhibitors of factor XII or activated factor XII
US8070678B2 (en) * 2005-10-05 2011-12-06 Gurbel Paul A Detection of restenosis risk in patients receiving a stent by measuring the characteristics of blood clotting including the measurement of maximum thrombin-induced clot strength
US8197420B2 (en) 2006-12-18 2012-06-12 Magnolia Medical Technologies, Inc. Systems and methods for parenterally procuring bodily-fluid samples with reduced contamination
WO2009046274A1 (en) * 2007-10-03 2009-04-09 The University Of Vermont And State Agriculture College Methods of detection of factor xia and tissue factor
JP5809058B2 (ja) 2008-10-15 2015-11-10 アイシス ファーマシューティカルズ， インコーポレーテッド 第１１因子発現の調節
US8448499B2 (en) 2008-12-23 2013-05-28 C A Casyso Ag Cartridge device for a measuring system for measuring viscoelastic characteristics of a sample liquid, a corresponding measuring system, and a corresponding method
US20120294767A1 (en) * 2011-05-19 2012-11-22 Hemosonics Llc Portable hemostasis analyzer
CN102262161B (zh) * 2011-08-16 2013-09-11 天津市百利康泰生物技术有限公司 水蛭素在特定条件下失活后检测凝血四项方面的应用
BR112014003787A2 (pt) * 2011-08-23 2020-10-27 Synapse B.V. inibidores termoestáveis de ativação do sistema de coagulação sanguínea por contato com superfícies estranhas
US8864684B2 (en) 2011-10-13 2014-10-21 Magnolia Medical Technologies, Inc. Fluid diversion mechanism for bodily-fluid sampling
US8535241B2 (en) 2011-10-13 2013-09-17 Magnolia Medical Technologies, Inc. Fluid diversion mechanism for bodily-fluid sampling
US20130149386A1 (en) * 2011-12-07 2013-06-13 Region Nordjylland Cd36 as biomarker for steatosis
US9022950B2 (en) 2012-05-30 2015-05-05 Magnolia Medical Technologies, Inc. Fluid diversion mechanism for bodily-fluid sampling
US9060724B2 (en) 2012-05-30 2015-06-23 Magnolia Medical Technologies, Inc. Fluid diversion mechanism for bodily-fluid sampling
US9204864B2 (en) 2012-08-01 2015-12-08 Magnolia Medical Technologies, Inc. Fluid diversion mechanism for bodily-fluid sampling
WO2014058945A1 (en) 2012-10-11 2014-04-17 Bullington Gregory J Systems and methods for delivering a fluid to a patient with reduced contamination
ES2985161T3 (es) 2012-11-30 2024-11-04 Magnolia Medical Technologies Inc Mecanismo de desviación de fluido basado en jeringa para muestreo de fluidos corporales
US10772548B2 (en) 2012-12-04 2020-09-15 Magnolia Medical Technologies, Inc. Sterile bodily-fluid collection device and methods
US10251590B2 (en) 2012-12-04 2019-04-09 Magnolia Medical Technologies, Inc. Sterile bodily-fluid collection device and methods
MX2015009914A (es) * 2013-02-01 2015-09-25 Becton Dickinson Co Dispositivos de recogida de sangre que contienen aditivos de inhibicion de la via de contacto.
WO2014164263A1 (en) 2013-03-12 2014-10-09 Bullington Gregory J Methods and apparatus for selectively occluding the lumen of a needle
US20150050677A1 (en) * 2013-08-16 2015-02-19 University Of Massachusetts Medical School Methods and systems for measuring whole blood platelet reactivity
RU2556116C2 (ru) 2013-11-28 2015-07-10 Общество с ограниченной ответственностью "Гематологическая Корпорация" (ООО "ГемаКор") Высокоселективный ингибитор контактной активации на основе инфестина 4
EP3721854B1 (de) 2014-03-03 2023-04-05 Magnolia Medical Technologies, Inc. Vorrichtung und verfahren zur desinfektion eines probenbehälters
US10816559B2 (en) 2014-09-29 2020-10-27 Ca Casyso Ag Blood testing system and method
US10539579B2 (en) 2014-09-29 2020-01-21 C A Casyso Gmbh Blood testing system and method
US11234626B2 (en) 2015-06-12 2022-02-01 Magnolia Medical Technologies, Inc. Devices and methods for syringe-based fluid transfer for bodily-fluid sampling
EP3344213B1 (de) 2015-09-03 2020-04-22 Magnolia Medical Technologies, Inc. System zum aufrechterhalten der sterilität eines probenbehälters
US10935560B2 (en) 2016-04-25 2021-03-02 Instrumentation Laboratory Company Method and kit for identifying lupus anticoagulant (LA) associated with antiphospholipid syndrome
EP4534203A3 (de) 2017-06-09 2025-05-21 Magnolia Medical Technologies, Inc. Fluidsteuerungsvorrichtungen und verfahren zur verwendung davon
EP3681384B1 (de) 2017-09-12 2022-12-28 Magnolia Medical Technologies, Inc. Ein system
EP3721086A4 (de) 2017-12-07 2021-11-10 Magnolia Medical Technologies, Inc. Fluidsteuerungsvorrichtungen und verfahren zur verwendung davon
CR20200605A (es) 2018-05-09 2021-01-29 Ionis Pharmaceuticals Inc Compuestos y métodos para la reducción de la expresión de fxi
EP3920801A1 (de) 2019-02-08 2021-12-15 Magnolia Medical Technologies, Inc. Vorrichtungen und verfahren zur sammlung und verteilung von körperflüssigkeiten
CN113784793B (zh) 2019-03-11 2023-09-19 木兰医药技术股份有限公司 流体控制装置及其使用方法
CN113325185B (zh) * 2021-07-09 2024-04-19 重庆鼎润医疗器械有限责任公司 多水平质控品及其制备方法和在血栓弹力图检测上的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4882272A (en) 1986-10-01 1989-11-21 Temple University - Of The Commonwealth System Of Higher Education High molecular weight kininogen assay
US5318910A (en) 1988-11-10 1994-06-07 International Technidyne Corp. Standard whole blood composition for determining the potency of blood clotting inhibitory substances
US5472850A (en) 1991-04-10 1995-12-05 Oklahoma Medical Research Foundation Quantitative clotting assay for activated factor VII
US5314826A (en) 1991-08-23 1994-05-24 Medtronic Hemotec, Inc. Platelet activation and function evaluation technique
US5705395A (en) 1994-11-14 1998-01-06 The Scripps Research Institute Method for diagnosis of thrombotic disorders
ATE274600T1 (de) * 1998-06-08 2004-09-15 Univ Vermont Verfahren zur bestimmung der blutgerinnung in plasma

Also Published As

Publication number Publication date
EP1084270A1 (de) 2001-03-21
AU757459B2 (en) 2003-02-20
EP1084270A4 (de) 2001-12-05
US6566140B2 (en) 2003-05-20
AU4548699A (en) 1999-12-30
WO1999064622A1 (en) 1999-12-16
JP2002517739A (ja) 2002-06-18
DE69919702T2 (de) 2005-09-15
US6403381B1 (en) 2002-06-11
CA2333890A1 (en) 1999-12-16
DE69919702D1 (de) 2004-09-30
EP1084270B1 (de) 2004-08-25
US20020042144A1 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
ATE274600T1 (de) Verfahren zur bestimmung der blutgerinnung in plasma
ATE209191T1 (de) Parazinon thrombin inhibitoren
WO2007026251A8 (en) Use of dual c-kit/fgfr3 inhibitors for treating multiple myeloma
DE59908887D1 (de) Verfahren zur ein- bzw. abschaltung von verbrauchern
WO2004037159A3 (en) Compounds, compositions and methods for modulating fat metabolism
WO2002077903A3 (en) Methods for determining the organization of a cellular component of interest
ATE446776T1 (de) Zusammensetzung zur gefässbeschichtung
DE60126961D1 (de) Verfahren und system zur handhabung von holzklötzen
AU1929199A (en) Methods for the recovery and measurement of troponin complexes
DE69828682D1 (de) Nanomolare, non-peptidische inhibitoren von cathepsin d
ATE238415T1 (de) Feste phytase-zusammensetzungen
WO2003059296A3 (en) Compositions comprising collagen and metalloprotease inhibitors
WO2004060768A8 (en) Method and material for multi-material wrapping of items
NZ331327A (en) Serine protease inhibitors having an acylguanidine side chain
AU3416200A (en) Method for determining the concentration of thrombin inhibitors
WO2002032435A3 (en) A composition including a platelet activating factor inhibitor and an antioxidant which interferes with the arachidonic acid cascade
MXPA01011859A (es) Medicamento para aplicacion localizada, que contiene fibrinogenos, trombinas, inhibidores de transglutaminasas y proteinasa.
EP1099442A3 (de) Verfahren zur Verabreichung von apo B-sekretion/MTP Inhibitoren
DE60022885D1 (de) Verfahren zur mürbmachen von fleisch
WO2001072778A3 (en) Method of identifying inhibitors of tie-2
BR0307633A (pt) Tiras finas feitas de liga de alumìnio-ferro
DK1216307T3 (da) Fremgangsmåde til detektion af rester af antimikrobielle midler
WO2001016300A3 (en) Method of identifying inhibitors of cdc25
AU2002364817A8 (en) Method for guaranteeing at least one characteristic of a fluid used for producing food products
DK1673057T3 (da) Hårvækstinhibering

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties